{{Rsnum
|rsid=7853758
|Gene=SLC28A3
|Chromosome=9
|position=84286011
|Orientation=plus
|GMAF=0.1804
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC28A3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 24.8 | 70.8
| HCB | 0.7 | 25.5 | 73.7
| JPT | 1.8 | 17.7 | 80.5
| YRI | 14.3 | 40.1 | 45.6
| ASW | 10.5 | 35.1 | 54.4
| CHB | 0.7 | 25.5 | 73.7
| CHD | 0.9 | 29.4 | 69.7
| GIH | 0.0 | 22.8 | 77.2
| LWK | 13.6 | 40.0 | 46.4
| MEX | 0.0 | 36.2 | 63.8
| MKK | 22.4 | 36.5 | 41.0
| TSI | 1.0 | 24.5 | 74.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=21900104
|Title=Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
}}

{{PMID Auto
|PMID=23441093
|Title=Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}